NCT06856499
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06856499
Title Cirtuvivint/Olaparib in Breast Cancer Susceptibility Gene/homologous Recombination Deficiency Platinum Resistant Ovarian Cancer
Recruitment Recruiting
Gender female
Phase Phase I
Variant Requirements No
Sponsors University of Colorado, Denver
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
CU Medicine Clinics RECRUITING Aurora Colorado 80045 United States Details
Universtiy of Colorado Hospital RECRUITING Aurora Colorado 80045 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field